Dichlorophenamide

双氯非那胺

Report date: 2024/05/09 13:40:59
NME

Base Information

Drug NameDichlorophenamide
Drug Alias NameDichlorphenamide双氯苯二磺酰胺Diclofenamide双氯磺酰胺二氯磺胺 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsParalysis, Hyperkalemic PeriodicHypokalemic Periodic Paralysis
Global Approved IndicationsParalysis, Hyperkalemic PeriodicHypokalemic Periodic Paralysis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesItalyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaro
China Registration ClassN/A

Develop Information

Active CompaniesStrongbridge Biopharma PlcXeris Pharmaceuticals Inc
Inactive CompaniesUniversity Of Rochester
Active IndicationsParalysis, Hyperkalemic PeriodicHypokalemic Periodic Paralysis
Inactive IndicationsN/A

Other Information

ATC CodeS01EC02
Related LinksWikipediaDrugBankKEGG